35 medical-physics "University Hospital Southampton" Fellowship positions at Universidade de Coimbra
Sort by
Refine Your Search
-
fellowship, in the framework of the R&D Unit “Laboratory for Instrumentation, Biomedical Engineering and Radiation Physics” (LIBPhys), reference UIDB/04559/2020, financed by Fundação para a Ciência e a
-
of resignation or withdrawal of the selected candidate, the next candidate with the highest evaluation score will be notified immediately. Once the selection process is completed, the fellowship contract will be
-
the highest evaluation score will be notified immediately. Once the selection process is completed, the fellowship contract will be drawn up in accordance with the draft contract provided by the FCT. After
-
waivers the fellowship. In case of resignation or withdrawal of the selected candidate, the next candidate with the highest evaluation score will be notified immediately. Once the selection process is
-
of the selected candidate, the next candidate with the highest evaluation score will be notified immediately. Once the selection process is completed, the fellowship contract will be drawn up in accordance with
-
selection process is completed, the fellowship contract will be drawn up in accordance with the draft contract provided by the FCT. After the contracted period, the fellowship holder and supervisor must
-
that the candidate waivers the fellowship. In case of resignation or withdrawal of the selected candidate, the next candidate with the highest evaluation score will be notified immediately. Once the selection process
-
score will be notified immediately. Once the selection process is completed, the fellowship contract will be drawn up in accordance with the draft contract provided by the FCT. After the contracted period
-
the fellowship. In case of resignation or withdrawal of the selected candidate, the next candidate with the highest evaluation score will be notified immediately. Once the selection process is completed
-
cell populations most effective in the internalization process will be identified. The cytotoxicity of the formulation will also be evaluated. 3- Bioactivity of an mRNA formulation in organotypic